Texas · Schedule I · active research
30 million Texans. Two clinical research sites. One legal pathway.
Texas runs the largest demand-supply gap of any US psilocybin policy environment. State law is strict — psilocybin is Penalty Group 2-A, possession is felony-level. State research is unusually well-funded — Baylor's STARLIGHT trial is recruiting in Houston, and the legislature committed up to $50M to ibogaine trials in 2025. The two facts don't contradict; they describe the same policy.
90-second quick read · research companion
Need the full research version?
This is the 90-second cliff-note read on imicrodosing.net. For the cited deep-dive companion, read the full .org research page before moving into product decisions.
Demand · supply
The largest gap in US psilocybin policy
Most US psilocybin coverage groups states by access tier — Oregon and Colorado have programs, decriminalised cities are next, strict-law states are last. Texas breaks the categorisation. The state has the highest absolute psilocybin search demand in the country, two state-funded research institutions running clinical trials, and zero personal-use access. The asymmetry is the story.
Texas is unique in funding clinical-grade psilocybin research while criminalising personal possession at felony levels. Both facts are true; both matter for what comes next.
Demand side
Largest US market with no access
- Population 30M
- Veteran population 1.4M
- HB 4813 vote (2025) 146–0
- Ibogaine trial fund (2025) $50M
Supply side
Two narrow legal pathways
- Active clinical trials 2
- Licensed dispensaries 0
- Decrim cities 0
- Personal-use legal pathway None
The gap. Texas is closer to building a state psilocybin industry through clinical research than through decriminalisation. HB 4813 — the auto-rescheduling bill — is what makes that pipeline functional once the FDA acts.
Three policy facts
What's actually happening in Texas right now
- HB 1802 is operational. Signed by Governor Abbott in 2021. It directs Baylor College of Medicine and the DeBakey VA Medical Center to study psilocybin for veteran PTSD. The resulting STARLIGHT Protocol (NCT06888128) is now recruiting in Houston.
- UT Austin's Center for Psychedelic Research and Therapy is the second institutional research bridge. Texas legislators amended 2025 bill text to formalise UT Austin alongside Baylor — the state now has two research anchors, not one.
- HB 4813 changes the access timeline. Passed unanimously in the House in 2025. It auto-reschedules substances under Texas law when the federal government reschedules them. If the FDA approves psilocybin (Breakthrough Therapy), Texas updates without requiring a new bill.
Cities
Where the supply pipeline lives
The four pages below address Texas at the metro level. Each city plays a different role in the demand-supply asymmetry. None of them currently provides legal access outside the research framework.
Austin
Policy · UT research
State capital. UT Austin Center for Psychedelic Research and Therapy. The legislative-cultural pressure point.
Austin pageDallas
Adjacency · ketamine
Largest North Texas metro. Densest ketamine-clinic infrastructure in the state — the closest legal proxy.
Dallas pageHouston
Active trial site
Baylor College of Medicine. DeBakey VA. STARLIGHT Protocol recruiting now — the only operational clinical access in Texas.
Houston pageSan Antonio
Military · veteran
Joint Base San Antonio. Brooke Army Medical Center. The veteran-population centre HB 1802 was written for.
San Antonio pageCommon questions
Texas psilocybin FAQ
Q · 01
Is psilocybin legal in Texas?
No. Psilocybin is Schedule I under the Texas Controlled Substances Act (Penalty Group 2-A). Possession of less than one gram is a state-jail felony; one to four grams is a third-degree felony with potential prison time. No Texas city has decriminalised personal possession. The only legal pathway to psilocybin in Texas right now is enrollment in an approved clinical trial.
Q · 02
What is the Baylor STARLIGHT Protocol?
A Phase 2 state-funded trial (NCT06888128) at Baylor College of Medicine and the Michael E. DeBakey VA Medical Center in Houston, studying psilocybin-assisted therapy for veterans with treatment-resistant PTSD. It is the direct outcome of HB 1802 (signed by Governor Abbott in 2021). Two-session protocol — 15mg low dose, then 25mg two weeks later. Currently recruiting.
Q · 03
What was HB 4813 and does it change current access?
HB 4813, sponsored by Rep. Tom Oliverson, passed the Texas House 146–0 in 2025. It auto-reschedules a substance under Texas state law when the federal government reschedules it — so if the FDA approves psilocybin (currently in Breakthrough Therapy designation), Texas updates without requiring a new state law. It does not legalise possession, but it materially shortens the access timeline.
While Texas remains strict
iMicrodosing.com ships lab-verified products within all applicable federal, state, and local laws. For deeper research and clinical context on psilocybin therapy outcomes — including the Baylor and Imperial trial literature — imicrodosing.org provides comprehensive data.